BTK and osteosarcoma: Targeted sequencing on the osteosarcoma tissue (tumor cell content 90%) applying the Tumor-Mutational Burden (TMB)-Panel revealed additional somatic variants in BTK, NF2 and FBXW7. Additionally, the pathogenic germline TP53 variant was detected.